Minoryx Therapeutics' Series B Round

Minoryx Therapeutics raised a round of funding on September 26, 2018.

Minoryx Therapeutics is a drug development company specializing in the discovery of new drugs for orphan diseases. The company targets Inborn Errors of Metabolism; a group of rare diseases of genetic …

Articles about Minoryx Therapeutics' Series B Round: